A comparative study on the effect of streptokinase between diabetic and non-diabetic myocardial infarction patients

Chowdhury, Md. Anup Rahman; Hossain, Amir; Dey, Sudhangshu Ranjan; Akhtaruzzaman, Akm; Islam, Nur-A-Farhana

doi:10.3329/bjp.v3i1.822

Cited by 6 publications

(1 citation statement)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Chaudhry et al (13), compared the efficacy of streptokinase between diabetic and nondiabetic patients presenting with acute ST Elevation Myocardial infarction. This study confirmed more complete ST-resolution in non-diabetic patients as compared to diabetic patients (non-diabetic group 48.4% vs. diabetic group 19.7%; p<0.001).…”

Section: Dr Ashish Chauhanmentioning

confidence: 99%

EFFICACY OF THROMBOLYSIS (STREPTOKINASE) IN DIABETIC AND NON-DIABETIC PATIENTS PRESENTING WITH ACUTE ST ELEVATION MI & COMPARISON OF THEIR ANGIOGRAPHIC PROFILE.

Chauhan

Gupta

Agarwal

2021

PIJR

View full text Add to dashboard Cite

BACKGROUND: To determine the efficacy of streptokinase in diabetic versus non-diabetic patients presenting with acute ST Elevation Myocardial Infarction (STEMI). METHOD AND RESULTS: This is a hospital based observational study conducted in the department of Cardiology, S.M.S. MEDICAL COLLEGE and associated hospital, Jaipur, Rajasthan between March 2016 to August 2017. Two hundred one consecutive patients of acute STEMI admitted to the Cardiology department were enrolled in the study to maintain 95% CI and 80% power of study. Patients with acute STEMI within 12 hours of chest pain without contraindications to fibrinolytic therapy (streptokinase) were included. ECG was done before and at 90 minutes after the start of streptokinase. ST-segment resolution equal to or more than 70% at 90 minutes on ECG was taken as successful reperfusion. The data was analysed by using software SPSS version 10. The quantitative variables were presented as mean and standard deviation while qualitative variables as frequency and percentage. Chi square test was used to estimate significance and p-value of <0.05 was considered significant. Out of 201 patients, 127(63.2%) were non-diabetics and 74(36.8%) were diabetics. The age of presentation of these patients was 32-75yr (meanage=55.59yr). Of these patients, 80% (N=160) were male and 20% (N=40) were female. Among the 74 diabetic patients, streptokinase was not effective in any patients. So streptokinase is non-efficacious in diabetic patients. Among the 127 non diabetic patients, streptokinase was effective in 79 (62.2%). Among the risk factors, smoking and hypertension were found in 84.6% and 62.7% of the patients respectively. So, we found smoking as the most common risk factor followed by HTN and DM in our patients. HTN was found significantly more in diabetic patients (94.59%) vs (44.09% in non-diabetic patients). On angiography, 58.7% patients had SVD, 34.8% had DVD and 6.5% had TVD. Five (2.5%) of these were found to have LM disease. Coronary angiography showed SVD, DVD, TVD in 44(59.46%), 17(22.97%) and 13(17.57%) of diabetic vs 74(58.27%), 53(41.73%) and 0(0%) of non-diabetic patients. So, triple vessel disease is significantly higher in diabetic patients. CONCLUSION: This study shows that streptokinase is significantly more efficacious in non-diabetics as compare to diabetic patients presenting with acute STEMI. It is more efficacious in male than female (M=47.82%; F=5%). We found that the window period of presentation was significantly higher in diabetic patient because of atypical symptoms that may lead to a delay in seeking medical advice and streptokinase was significantly more efficacious in non-diabetics as compare to diabetic patients.

show abstract

Section: Dr Ashish Chauhanmentioning

confidence: 99%

EFFICACY OF THROMBOLYSIS (STREPTOKINASE) IN DIABETIC AND NON-DIABETIC PATIENTS PRESENTING WITH ACUTE ST ELEVATION MI & COMPARISON OF THEIR ANGIOGRAPHIC PROFILE.

Chauhan

Gupta

Agarwal

2021

PIJR

View full text Add to dashboard Cite

show abstract

Comparative Outcome Study between Resolved and Unresolved St Segment in St Segment Elevation Acutemyocardial Infarction (STEMI) after Thrombolytic Therapy

Kamthe

Chafekar

2023

MVP.J.M.S

View full text Add to dashboard Cite

Background: To study the comparative outcome between resolved an unresolved ST segment in ST Segment Elevation Acute Myocardial Infarction (STEMI), after thrombolytic therapy. Method: A study was carried out on patients admitted with 1st episode of ST elevated myocardial infarction in MICU of a tertiary health care center of a teaching hospital. On admission detailed history was taken and a complete clinical examination was done. Thrombolysis was done using streptokinase, 2D ECHOs were performed before and after thrombolytic therapy. Result: Most of the study population in both the group (Unresolved STEMI and Successful thrombolysis), belonged to the age group of 41 to 50 years. Co-morbidities like hypertension were present in 83% of Unresolved STEMI and 53% of Resolved STEMI. Comorbidities like diabetes were present in 66.7% of Unresolved STEMI and 52.6% of Resolved STEMI. RWMA on 2D-Echo before thrombolysis was present in 58.3% of Unresolved STEMI and 47.4% of Resolved STEMI. RWMA on 2D-Echo after thrombolysis was present in 66.7% of Unresolved STEMI and 18.5% of Resolved STEMI. Conclusion: Symptom to needle time is an important predictor of whether thrombolysis will be successful or not in acute myocardial infarction patients. Hence it is important to educate the public about prompt recognition of symptoms and seeking medical help urgently. As the rate of unsuccessful thrombolysis is higher in patients with old age, diabetes, hypertension and dyslipidemia, such patients should be monitored and treated aggressively.

show abstract

Coronary Angiographic Patency in Patients With Acute Myocardial Infarction With or Without Thrombolytic Therapy

et al. 1970

View full text Add to dashboard Cite

show abstract

A comparative study on the effect of streptokinase between diabetic and non-diabetic myocardial infarction patients

Cited by 6 publications

References 21 publications

EFFICACY OF THROMBOLYSIS (STREPTOKINASE) IN DIABETIC AND NON-DIABETIC PATIENTS PRESENTING WITH ACUTE ST ELEVATION MI & COMPARISON OF THEIR ANGIOGRAPHIC PROFILE.

EFFICACY OF THROMBOLYSIS (STREPTOKINASE) IN DIABETIC AND NON-DIABETIC PATIENTS PRESENTING WITH ACUTE ST ELEVATION MI & COMPARISON OF THEIR ANGIOGRAPHIC PROFILE.

Comparative Outcome Study between Resolved and Unresolved St Segment in St Segment Elevation Acutemyocardial Infarction (STEMI) after Thrombolytic Therapy

Coronary Angiographic Patency in Patients With Acute Myocardial Infarction With or Without Thrombolytic Therapy

Contact Info

Product

Resources

About